Ambrx Biopharma Inc.
USD28.00
+0.02 (+0.07%)
CEO
Daniel J. O'Connor
IPO Date
2023-08-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$27.99
Prev. Close
$27.98
Day Low
$27.98
Day High
$28.00
52W Low
$6.55
52W High
$28.15
Market Cap
$1.77B
Volume
1.42M
| 50,012 |
| $9.82 |
| 25 Oct 2023 | Cormorant Asset Management, LP | 10 percent owner | P-Purchase | Acquired | 1,307,311 | $6.99 |
| 19 Sept 2023 | Cormorant Asset Management, LP | 10 percent owner | P-Purchase | Acquired | 751,233 | $9.24 |
| 19 Sept 2023 | Cormorant Asset Management, LP | 10 percent owner | P-Purchase | Acquired | 1,401,505 | $9.05 |
| 6 Sept 2023 | DALESANDRO MARGARET | director | A-Award | Acquired | 125,000 | $0.00 |
| 6 Sept 2023 | DALESANDRO MARGARET | director | A-Award | Acquired | 70,833 | $0.00 |
| 6 Sept 2023 | DALESANDRO MARGARET | — | Disposed | 0 | $0.00 |
| 7 Jul 2023 | Nelson Sonja | Chief Financial Officer | A-Award | Acquired | 389,000 | $2.38 |
| 7 Jul 2023 | O'Connor Daniel J. | director, officer: President and CEO | A-Award | Acquired | 1,216,500 | $2.38 |